Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36223558

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Feb 20
First author
Brahmer JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Feb 20;41(6):1172-1175. doi: 10.1200/JCO.22.02278.
    note
    Source null
    related pmid
    36623229
    relationship
    Comment in

Authors and identifiers

  1. name
    Brahmer JR
    type
    Author
  2. name
    Lee JS
    type
    Author
  3. name
    Ciuleanu TE
    type
    Author
  4. name
    Bernabe Caro R
    type
    Author
  5. name
    Nishio M
    type
    Author
  6. name
    Urban L
    type
    Author
  7. name
    Audigier-Valette C
    type
    Author
  8. name
    Lupinacci L
    type
    Author
  9. name
    Sangha R
    type
    Author
  10. name
    Pluzanski A
    type
    Author
  11. name
    Burgers J
    type
    Author
  12. name
    Mahave M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Brahmer JR
    type
    Author
  2. name
    Lee JS
    type
    Author
  3. name
    Ciuleanu TE
    type
    Author
  4. name
    Bernabe Caro R
    type
    Author
  5. name
    Nishio M
    type
    Author
  6. name
    Urban L
    type
    Author
  7. name
    Audigier-Valette C
    type
    Author
  8. name
    Lupinacci L
    type
    Author
  9. name
    Sangha R
    type
    Author
  10. name
    Pluzanski A
    type
    Author
  11. name
    Burgers J
    type
    Author
  12. name
    Mahave M
    type
    Author
bibliography ids
  1. nci-bib-a11e98ae3a8d8debda105d02
book metadata
content sha256
dc03285b15435978a6a1f979ca0f89202950ddfe27f507f4be10332ed39e6c20
document type
citation
dois
  1. 10.1200/JCO.22.01503
electronic publication date
display
2022 Oct 12
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36223558
immutable id
pubmed:36223558@dc03285b15435978a6a1f979ca0f89202950ddfe27f507f4be10332ed39e6c20
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
6
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1200-1212
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Feb 20;41(6):1172-1175. doi: 10.1200/JCO.22.02278.
    note
    Source null
    related pmid
    36623229
    relationship
    Comment in
outcomes validated
false
pmid
36223558
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
b3f3e18924ab8a9f46fb3a2b7499051f07bdd1e010d8c1e1d27d60688c5509b7
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Feb 20
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36223558/
title
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.

Preserved source evidence · Not medical advice